Performance Support

Whether you are looking for information on MDS classification descriptions or other reference materials, the Performance Support page is the place to secure the information you need.

MDS Performance Support Web Resources
Educational Session at 2013 ASCP Annual Meeting: The Diagnosis, Classification, and Clinical Care of Myelodysplastic Syndromes (DC³-MDS)
Download slides >>
Download references >>

Information and resources: myelodysplastic syndromes. Aplastic Anemia and MDS International Foundation website. http://www.aamds.org/health-professionals. Accessed July 1, 2015.

General information about myelodysplastic syndromes. National Cancer Institute website. http://www.cancer.gov/cancertopics/pdq/treatment/myelodysplastic/Patient/page1. Updated May 10, 2013. Accessed August 5, 2013.

Additional resources for clinicians, researchers, and healthcare professionals. MDS Foundation website. http://www.mds-foundation.org/for-healthcare-professionals/. Accessed August 5, 2013.

Information and resources: myelodysplastic syndrome (MDS). WebMD website. http://www.webmd.com/a-to-z-guides/myelodysplastic-syndrome-causes-symptoms-treatment. Accessed August 5, 2013.

The MDS Beacon. http://www.mdsbeacon.com/. Accessed August 5, 2013.

Sekeres MA. The myelodysplastic syndromes. Cleveland Clinic website. http://www.clevelandclinicmeded.com/medicalpubs/diseasemanagement/hematology-oncology/myelodysplastic-syndromes/. Accessed August 5, 2013.

Zhou J OA, Czader MB. Myelodysplastic syndromes [abstract]. PubMed website. http://www.ncbi.nlm.nih.gov/pubmed/22195404. Accessed August 5, 2013.

Related articles from the PubMed website:
http://www.ncbi.nlm.nih.gov/pubmed?linkname=pubmed_pubmed&from_uid=22571693

Navada SC, Chatalbash A, Silverman LR. Clinical significance of cytogenetic manifestations in myelodysplastic syndromes. Lab Medicine. 2013;44:103-107. doi:10.1309/LMSZ0MFKXTY4PGL1. http://labmed.ascpjournals.org/content/44/2/103.full.pdf+html?sid=bc6363c1-f1d7-45da-8313-f682f7f8f730. Accessed August 2, 2013. Subscription required.

KussickSJ. Multiparametric flow cytometry in the diagnosis of myelodysplastic syndromes and related disorders. Lab Medicine. 2007;38:305-313. doi:10.1309/VTUQH4UBKVA810Q6. http://labmed.ascpjournals.org/content/38/5/305.full.pdf+html?sid=bc6363c1-f1d7-45da-8313-f682f7f8f730. Accessed August 2, 2013.

Haddad A, Maciejewski JP, Kalaycio M. Clinical significance of cytogenetics in myelodysplastic syndromes. Lab Medicine. 2008;39:367-370. doi:10.1309/EWKEBC48R8KYETR3. http://labmed.ascpjournals.org/content/39/6/367.full.pdf+html?sid=bc6363c1-f1d7-45da-8313-f682f7f8f730. Accessed August 2, 2013.

Rosas K, Van Siclen CP. Pancytopenia with predominant thrombocytopenia in a 37-year-old female with Li Fraumeni syndrome. Lab Medicine. 2013;44:e25-e28. doi:10.1309/LM216TEXPGUYDRUG. http://labmed.ascpjournals.org/content/44/2/e25.full.pdf+html?sid=bc6363c1-f1d7-45da-8313-f682f7f8f730. Accessed August 2, 2013. Subscription required.

King B. Diagnosis of de novo acute myelogenous leukemia with myelodysplasia related changes. Lab Medicine. 2013;44:e29-e34. doi:10.1309/LMH2V2BFSZG7XKWD. http://labmed.ascpjournals.org/content/44/2/e29.full.pdf+html?sid=bc6363c1-f1d7-45da-8313-f682f7f8f730. Accessed August 2, 2013. Subscription required.

Park SI, Richards KL. Antibody-based immunotherapeutic agents for treatment of non-Hodgkin lymphoma. Lab Medicine. 2013;44:108-113. doi:10.1309/LMWAT6W5LT3TIPVX. http://labmed.ascpjournals.org/content/44/2/108.full.pdf+html?sid=bc6363c1-f1d7-45da-8313-f682f7f8f730. Accessed August 2, 2013. Subscription required.

Fengqin F, Kezi M, Li Z, et al. The complex relationship of CMV IgM, pp65 antigenemia, plasma, and cellular HCMV Q-PCR as observed in an immunocompetent population and in HSCT patients. Lab Medicine. 2010;41:353-359. doi:10.1309/LMU62G9YADOGJEQF. http://labmed.ascpjournals.org/content/41/6/353.full.pdf+html?sid=bc6363c1-f1d7-45da-8313-f682f7f8f730. Accessed August 2, 2013.

Brent BJ, Nandedkar M. Vulvar and oral lesions in a 34-year old woman. Lab Medicine. 2005;36:644-646. doi:10.1309/U2C4K93YP20CP78T. http://labmed.ascpjournals.org/content/36/10/644.full.pdf+html?sid=bc6363c1-f1d7-45da-8313-f682f7f8f730. Accessed August 2, 2013.

Lee R. Comparison of inbound and outbound diagnoses for samples submitted for flow cytometric analysis. Lab Medicine. 2007;38:240-243. doi:10.1309/7HPMHN9K6K9J4J7D. http://labmed.ascpjournals.org/content/38/4/240.full.pdf+html?sid=bc6363c1-f1d7-45da-8313-f682f7f8f730. Accessed August 2, 2013.

Podberezin M, Angeles R, Peace D, et al. Acute myeloid leukemia with myelodysplasia-related changes. Lab Medicine. 2009;40:397-400. doi:10.1309/LMHEN4FTDQ3F2MYU. http://labmed.ascpjournals.org/content/40/7/397.full.pdf+html?sid=4c9b5b2c-6ce4-42ef-b2f5-9906502d76b9. Accessed August 2, 2013.

Constantino BT. Pelger-Huët Anomaly—Morphology, Mechanism, and Significance in the Peripheral Blood Film. Lab Medicine. 2005;36:103-107. doi:10.1309/HW3WCYXNDYYKEQ38. http://labmed.ascpjournals.org/content/36/2/103.full.pdf+html?sid=4c9b5b2c-6ce4-42ef-b2f5-9906502d76b9. Accessed August 2, 2013.

Shah J, Theil K, Kalaycio M. Clinical significance of cytogenetics in acute leukemias. Lab Medicine. 2003;34:796-802. doi:10.1309/03CVN1JH4DA08M5M. http://labmed.ascpjournals.org/content/34/11/796.full.pdf+html?sid=4c9b5b2c-6ce4-42ef-b2f5-9906502d76b9. Accessed August 2, 2013.

Olteanu H, Xu Y. The Use of Flow Cytometry in Diagnosis of Paroxysmal Nocturnal Hemoglobinuria. Lab Medicine. 2006;37:498-502. doi:10.1309/NAAH5J8DV43C0H7N. http://labmed.ascpjournals.org/content/37/8/498.full.pdf+html?sid=4c9b5b2c-6ce4-42ef-b2f5-9906502d76b9. Accessed August 2, 2013.

Clark M. Chronic myelomonocytic leukemia transforming into acute myelogenous leukemia. Lab Medicine. 2009;40:19-21. doi:10.1309/LMBP4DPLJ5G0WXQR. http://labmed.ascpjournals.org/content/40/1/19.full.pdf+html?sid=4c9b5b2c-6ce4-42ef-b2f5-9906502d76b9. Accessed August 2, 2013.

Strefford, JC, Harrison CJ. Advances in molecular cytogenetics to study the leukemia genome. Lab Medicine. 2007;38:527-535. doi:10.1309/JL7FK85EBGMWH4FL. http://labmed.ascpjournals.org/content/38/9/527.full.pdf+html?sid=4c9b5b2c-6ce4-42ef-b2f5-9906502d76b9. Accessed August 2, 2013.

Wyrick-Glatzel J, MacDonald JK, Chen J. Paroxysmal nocturnal hemoglobinemia: a molecular definition of the clinical biology of the disorder. Lab Medicine. 2006;37:237-243. doi:10.1309/1FC9D6QFBMBJ56DR. http://labmed.ascpjournals.org/content/37/4/237.full.pdf+html?sid=9a9758f0-1007-4547-bf73-baa1855be198. Accessed August 2, 2013.